4
Changes in Ownership
Olema Oncology, Inc. Filed Acc 0001415889-24-006322
Director sold 25,000 shares at an average $12.41 ($310,309)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Harmon Cyrus Director | 2024-02-29 | Sale 10b5-1 | −24,900 | $12.41 | $309,009 | 846,383 | D |
| Harmon Cyrus Director | 2024-02-29 | Sale 10b5-1 | −100 | $13.00 | $1,300 | 846,283 | D |
| Open-market sales · 25,000 sh · avg $12.41 · $310,309 | |||||||
Loading xslF345X05/form4-03042024_050305.xml…